Suppliers / Hunan Xiangyikang Pharmaceutical

Hunan Xiangyikang Pharmaceutical

China Updated 9 July 2026

Hunan Xiangyikang Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file. Its most recent recorded inspection, by US FDA, closed on 21 November 2025 as OAI.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 November 2025 OAI US FDA
  • 18 May 2018 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3013723309

What they file, and where

Molecule Regulators Docs
Sulfadiazine US FDA 1

Questions about Hunan Xiangyikang Pharmaceutical

Does Hunan Xiangyikang Pharmaceutical hold a US DMF or a CEP?
Hunan Xiangyikang Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Hunan Xiangyikang Pharmaceutical FDA-registered?
One site operated by Hunan Xiangyikang Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Hunan Xiangyikang Pharmaceutical's last inspection go?
The most recent inspection on record closed on 21 November 2025 as OAI (Official Action Indicated, the worst classification: objectionable conditions were found and regulatory action was warranted). 2 inspections are on file, of which 1 closed as OAI.
Where does Hunan Xiangyikang Pharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Hunan Xiangyikang Pharmaceutical make?
1 molecule is on record against Hunan Xiangyikang Pharmaceutical, including Sulfadiazine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Hunan Xiangyikang Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was OAI, on 21 November 2025.

Comparable suppliers

Acrobiosystems also in China AMHWA Biopharm Co.,Ltd also in China Anhui Apeloa Biotechnology also in China Anqui Lu'an Pharmaceutical Co.,Ltd also in China Argus Pharmaceuticals also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability